For conducting a simple test for the presence of pyrogens in drinking water, medical practitioners look into using portable pyrogen testing equipment. This product is specifically designed to provide results in a matter of minutes. These tests are performed on human and canine samples alike, providing results instantly. This type of portable Pyrogen Tester has been used by thousands of businesses and industries worldwide to ensure the safety of their employees and their communities.
Geographically, the North American region is boding well for the pyrogen testing market in the light of well-established healthcare infrastructure and increased spending on research and development of medical testing equipment. Similarly, rising awareness regarding public safety and an increasing number of drug clearances are accommodating the pyrogen testing market in the Asia Pacific region.
When the urine or blood samples are tested from either human or canine subjects, the probe is introduced into the vial via an intravenous needle and held beneath the skin surface for immediate results. These results can often be seen within a few seconds after the needle is inserted, providing conclusive evidence of the presence of pyrogens within the subject's blood or urine. Many animal studies have shown that chronic exposure to exogenous pyrogens can result in serious health consequences for both humans and animals. Animal studies have also shown that the long-term inhalation of exogenous pyrogens may result in cancer-related symptoms in humans. Exogenous pyrogens are particularly frequently detected in individuals with chronic illnesses or those who may be at higher risk of developing cancer or other serious health conditions, such as women of childbearing age, smokers, or individuals who may have preexisting gastrointestinal problems or respiratory problems.
In June 2020, Lonza partnered with Sanquin to develop reliable techniques for in-vitro pyrogen testing procedures that will enhance drug development. Later in October 2020, Lonza launched the PyroCell MAT System for in-vitro pyrogen testing to secure drug discovery and its production.
The amalgamation of factors such as the increased R&D activities in the biotechnology and pharmaceutical sectors, escalating incidence of chronic diseases, heightened recognition of food safety, increased dependence on customized medicine, and frequent occurrence of viral infections and pandemics such as the COVID-19 virus is broadening the scope for the pyrogen testing market.
Additionally, the development of the pyrogen testing market is aided by significant government backing for the pharmaceutical and healthcare sectors. On the contrary, higher costs associated with the production and R&D activities are limiting the growth aspects of the pyrogen testing market.